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The hepatic metabolism of benzene is thought to be a prerequisite for its bone marrow toxicity.
However, the complete pattern of benzene metabolites formed in the liver and their role in bone
marrow toxicity are not fully understood. Therefore, benzene metabolism was studied in isolated
rodent hepatocytes. Rat hepatocytes released benzene-1,2-dihydrodiol, hydroquinone (HQ),
catechol (CT), phenol (PH), trans-trans-muconic acid, and a number of phase 11 metabolites such
as PH sulfate and PH glucuronide. Pretreatment of animals with 3-methylcholanthrene (3-MC)
markedly increased PH glucuronide formation while PH sulfate formation was decreased. Likewise,
V79 cells transfected with the 3-MC-inducible rat UGT1.6 cDNA showed a considerable rate of
PH and HQ glucuronidation. In addition to inducing glucuronidation of phenols, 3-MC treatment
(reported to protect rats from the myelotoxicity of benzene) resulted in a decrease of hepatic
CYP2E1. In contrast, pretreatment of rats with the CYP2E1-inducer isopropanol strongly enhanced
benzene metabolism and the formation of phenolic metabolites. Mouse hepatocytes formed much
higher amounts of HQ than rat hepatocytes and considerable amounts of 1,2,4-trihydroxybenzene
(THB) sulfate and HQ sulfate. In conclusion, the protective effect of 3-MC in rats is probably due
to a shift from the labile PH sulfate to the more stable PH glucuronide, and to a decrease in
hepatic CYP2E1. The higher susceptibility of mice toward benzene may be related to the high
rate of formation of the myelotoxic metabolite HQ and the semistable phase 11 metabolites HQ
sulfate and THB sulfate. Environ Health Perspect 104(Suppl 6):1 183-1188 (1996)
Key words: benzene metabolism, cytochrome P4502E1, drug-metabolizing enzymes,
glucuronidation, hepatocytes, hydroquinone formation, inducers of drug metabolism, sulfate
conjugates, UDP-glucuronosyltransferase
Introduction
It is widely accepted that the bone marrow releasing myelotoxic or pro-myelotoxic
toxicity and carcinogenicity of benzene benzene metabolites into the systemic circu-
results from the action of reactive metabo- lation (1,2). Principal pathways ofhepatic
lites that damage essential cellular macro- benzene metabolism include the formation
molecules in the target organ, thus leading ofphenolic metabolites and their conju-
to decreased proliferation, cell death, and gates, and of the ring-opened trans-trans-
genotoxicity. A number offindings indicate muconaldehyde and its oxidation products
that the metabolism ofbenzene in the liver (3). However, the metabolites ultimately
plays an important role in this scenario by responsible for bone marrow toxicity still
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have to be identified. Application ofsingle
metabolites of benzene such as phenol
(PH), catechol (CT), hydroquinone (HQ),
and 1,2,4-trihydroxybenzene (THB) to
rodents failed to reproduce the characteristic
toxic effects ofbenzene in the bone marrow
(4,5). In several studies the possible syner-
gistic action ofcertain metabolites ofben-
zene on the bone marrow was investigated.
Itwas shown that PH enhanced the conver-
sion of HQ into 1,4-benzoquinone cat-
alyzed in vitroby myeloperoxidase (6,7), an
enzyme present in abundance in the bone
marrow (8). The electrophilic 1,4-benzo-
quinone thus formed is able to bind to cel-
lular proteins and DNA. Binding to critical
proteins such as tubulin (9) or DNA poly-
merase-a (10) may play an important role
in benzene toxicity.
In vivo experiments by Eastmond et al.
(11) demonstrated that combined but not
single treatment of rats with HQ and PH
led to a decrease in bone marrow cellularity,
while CT was ineffective when combined
with either PH or HQ. In a report by Guy
et al. (12) the combination of muconal-
dehyde and HQ was reported to inhibit
erythroid iron utilization in mice in a syn-
ergistic manner. These studies demonstrate
the central role ofphenolic metabolites in
the myelotoxicity ofbenzene.
In this report we show that pretreat-
ment of rats with 3-methylcholanthrene
(3-MC) leads to a shift from sulfation to
glucuronidation of phenol, the major
phase I metabolite ofbenzene. Induction of
a phenol glucuronosyltransferase (UGT 1.6)
may thus protect the organism by forming
stable glucuronides instead ofsemistable sul-
fates. Since inhalation experiments had
revealed significantly higher levels ofvari-
ous benzene metabolites such as HQ, HQ
glucuronide, and trans-trans-muconic acid
in mice compared to rats (13), we investi-
gated the pattern ofbenzene metabolites
released from isolated hepatocytes ofNMRI
mice to elucidate whether differences in
benzene metabolism might contribute to
the observed differences in metabolite levels
and myelotoxicity (14). Major differences
were found in the formation ofsulfate con-
jugates of phenolic benzene metabolites
between mouse and rathepatocytes.
Materials and Methods
Chemicals
14C-Benzene was obtained from Amersham
(Braunschweig, Germany) at a radiochemical
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and chemical purity of > 99.5%. It was
diluted with unlabeled HPLC-grade
benzene (Baker, Gross-Gerau, Germany)
to a specific activity of 37 MBq/mmol.
Collagenase type IV was from Sigma
(Taufkirchen, Germany) or from Boehringer
(Mannheim, Germany). HQ sulfate was
obtained from TCI Chemicals (Tokyo,
Japan). Benzene-1,2-dihydrodiol was a
generous gift of Prof. F. Oesch (Institute
of Toxicology, University of Mainz,
Mainz, Germany).
Animal
Male Wistar rats weighing 220 to 240 g,
and male NMRI mice weighing 20 to 24 g,
were obtained from Savo (Kisslegg,
Germany) and the breeding station of the
GSF (Neuherberg, Germany), respectively.
The animals were kept under standard
conditions, and had free access to labora-
tory chow (Altromin, Lage, Germany) and
drinking water. Isopropanol (2.5 ml/kg)
was applied by gavage as dilution in saline
24 hr before sacrifice. 3-MC (40 mg/kg, ip,
dissolved in corn oil) was adminstered
3 days before sacrifice, and phenobarbital
was given by a single ip injection of 100
mg/kg (dissolved in saline) followed by
application in drinking water (0.1%, w/v)
over 3 days. Control rats received saline or
corn oil injections, respectively.
Hepatocyte Preparation
andIncubation
For hepatocyte preparation animals were
anesthetized with pentobarbital sodium
(100 mg/kg bw), and the liver was perfused
in situ via the portal vein using the sequen-
tial ethyleneoxyethylenenitrilotetraacetic
acid (EGTA)/calcium-collagenase method.
Rat hepatocytes were prepared as described
by Schrenk and Bock (15). Only cell
preparations exceeding a viability of 90%
were used for incubations.
For preparation of mouse hepatocytes,
livers were perfused sequentially with
50 ml preperfusion buffer 1 (Ca2+-free
modified Hank's medium containing
100 pM [EGTA]), with 50 ml pre-perfu-
sion buffer 2 (Ca2+-free modified Hank's
medium, without EGTA), andwith 100 ml
of Dulbecco's minimal essential medium
(DMEM) containing 1.8 mM CaCl2 and
12 U collagenase/100 ml at a flow rate of
10 ml/min. Then cells were dispersed in
DMEM containing 1% albumin. After
filtration through 80-pm and subsequently
through 40-pm nylon mesh filters, the cells
were washed 3 times in DMEM at 50g
for 45 sec. Viability, as determined by
exclusion of 0.4% Trypan Blue, was
greater than 85%.
14C-Benzene (0.5 mM; final specific
activity 37 MBq/mmol) was incubated
with 20x 106 freshly isolated hepatocytes
for 1 hr in 20 ml Krebs-Ringer buffer
(NaCl 7.0 g/liter, KCI 0.36 g/liter,
MgSO4x7 H20 0.295 g/liter, KH2PO4
0.163 g/liter, NaHCO3 2.016 g/liter)
supplemented with 5 mM HEPES, 10
mM D-glucose, 5 mM Na2SO4, and 20 g
bovine serum albumin per liter as previ-
ously described (15). Incubations were
performed in airtight Erlenmeyer flasks
(250 ml) which were gently shaken.
SeparationandQuantification
ofMetabolites
After addition of 10 mM ascorbic acid to
avoid oxidation ofmetabolites, the incuba-
tions were stopped by adding 2 vol ofice-
cold methanol, flushed with nitrogen, and
kept on ice for 30 min. Then, precipitated
protein was removed by centrifugation.
Supernatants were evaporated to dryness,
redissolved in 1 ml methanol, and aliquots
were analyzed on a high performance liq-
uid chromatography (HPLC) system as
described by Schrenk and Bock (15).
Metabolites were detected using a Lambda-
Max 491 UV-detector (Millipore, Dreieich,
Germany) at 280 nm and a Beckmann 171
radioisoptope detector (Beckman Instru-
ments, Fullerton, CA). The radiodetector
was set for liquid scintillation using Ultima
Gold scintillation cocktail (Packard
Instruments, Meriden, CT) at a flow rate
of 3 ml/min. Alternatively, fractions of
0.3 min were collected and quantified by
liquid scintillation counting.
IdentificationofMetabolites
The metabolites PH sulfate, PH glucuro-
nide, S-phenylglutathione, CT, HQ, PH,
benzene-1,2-dihydrodiol, and metabolite
G (presumably trans-trans-muconic acid)
were identified after preparative HPLC as
described by Schrenk and Bock (15). Two
novel benzene metabolites separated by
HPLC analysis ofsupernatants from mouse
hepatocyte incubations were isolated by
preparative HPLC. Fractions eluting at the
respective retention intervals were col-
lected. After adjustment to pH 7.8, frac-
tions were evaporated to dryness, kept
under nitrogen, and were analyzed by Fast
atom bombardment (FAB) mass spectrom-
etry using a Varian MAT 71 IA mass spec-
trometer (Varian, Bremen, Germany) after
dissolving the sample in a glycerol matrix.
Alternatively, the samples were analyzed in
a Finnigan 4021 mass spectrometer
(Finnigan, San Jose, CA) using electron
impact (EI) mass spectrometry, after deriva-
tization with N-methyl-N-(trimethyl-
silyl)trifluoroacetamide (MSTFA).
ImmnunoblottingofCYP2E1
Microsomes were prepared from isolated
hepatocytes, and microsomal proteins were
separated by SDS-PAGE, transferred to
Immobilon P sheets (Millipore, Dreieich,
Germany), and incubated with rabbit
anti-CYP2E1 IgG as described by Schrenk
and Bock (15). Immunoreactive bands
were visualized by incubation with peroxi-
dase-conjugated swine anti-rabbit IgG
and subsequent reaction with 4-chloro-1-
naphthol/H202-
Glucuronidation Experiments
Glucuronidation ofphenols was studied in
rat liver microsomes or in V79 Chinese
hamster lung fibroblasts. Liver microsomes
were prepared as described by Bock and
White (16) and were incubated with 200
pM HQ under the same conditions as
described for PH (15). After addition of
10 mM ascorbic acid to avoid oxidation,
the incubations were stopped by adding
2 vol of ice-cold methanol, flushed with
nitrogen, and kept on ice for 30 min. Then,
precipitated protein was removed by cen-
trifugation. Supernatants were evaporated
to dryness, redissolved in 1 ml methanol,
and aliquots were analyzed on the HPLC
system used for benzene metabolites. A
distinct peak of HQ monoglucuronide
eluting slightly earlier than HQ was
detected by UV absorbance (280 nm) and
was quantified by peak area integration.
Both wild-type V79 cells and a clone
stably transfected with the rat UGT1.6
cDNA were cultured as described by Bock
et al. (17). HQ or PH was freshly dis-
solved in sterile phosphate-buffered saline
and was added to the culture dishes. After
various time points, aliquots ofthe super-
natants were removed and HQ glucuro-
nide or phenylglucuronide were separated
and quantified by HPLC/UV detection.
Both glucuronides could be identified
by FAB-MS.
Results
In addition to a number of highly polar
metabolites designated as fraction A, seven
radioactive peaks could be separated from
supernatants of rat hepatocytes incubated
with 14C-labeled benzene (Figure 1).
Further analysis ofpeak 3 revealed the pres-
ence oftwo metabolites that were identified
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by mass spectrometry (not shown) as
phenylsulfate and S-phenylglutathione
(15). Based on the amount ofradioactivity,
a quantitative pattern of metabolites was
obtained (Table 1). In hepatocytes from
untreated rats, PH sulfate, PH glucuro-
nide, and S-phenylglutathione represented
the major metabolites, while benzene-1,2-
dihydrodiol, HQ, HQ glucuronide, CT,
and unconjugated phenol (PH) were
formed in smaller amounts. Another
metabolite, possibly trans-trans-muconic
acid, could not be identified because the
amount formed was insufficient for mass
spectrometric identification.
While total metabolism (at a substrate
concentration of0.1 mM) was not affected
by pretreatment with 3-MC or phenobar-
bital (PB), 3-MC caused a significant
increase in PH glucuronide formation at
the expense of PH sulfate and unconju-
gated PH. In contrast, isopropanol pretreat-
ment resulted in a pronounced increase in
total metabolism and in the release of a
3
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tion ofHQwas also found to be markedly
inducible by 3-MC and, to a lower extent,
by PB (Figure 2). From Lineweaver-Burk
diagrams an apparent Km value for the
high-affinity UGT activity toward HQ of
approximately 0.1 mM was calculated (not
shown). Figure 3 shows the time course of
glucuronidation of PH and HQ in V79
cells stably expressing rat UGT 1.6 cDNA,
an isozyme that is induced in rat liver
by 3-MC treatment. While almost no
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Figure 1. HPLC radiochromatogram of 14C-benzene metabolites formed in isolated rat hepatocytes. Hepatocytes ear
(20x106/20 ml) were incubated for 1 hr with 0.5 mM 14C-benzene (specific activity, 37 MBq/mmol). Fractions were expi
collected at 0.3-min intervals and radioactivity was determined by liquid scintillation counting. Numbers represent
polar metabolites (A), benzene-1,2-dihydrodiol (1), hydroquinone/hydroquinone glucuronide (2), phenylsulfate/S-
phenylglutathione (3), catechol (4), phenylglucuronide (5), unidentified metabolite coeluting with trans-trans-
muconic acid (6), phenol (7).
Table 1. Pattern of benzene metabolites formed in isolated rat hepatocytesa: effects of inducers.
nmol/hrx106CellSb
Metabolite Control Phenobarbital 3-MC Isopropanol
E Polar metabolitesc 0.18 ± 0.04 0.22 ± 0.05 0.30± 0.06 0.37 ±0.09* E
Benzen:i,2-dihdrJod 0 0.07 0.0 03 ... ...3 ...3.± 8*
Hydroquinone/HQglucuronide 0.20 ± 0.06 0.20± 0.07 0.13± 0.06 1.76± 0.31*
Phenlsfate ::94±0:15 0.71 aa0.11: :: :.: 1.51
Phenylglutathione 0.32± 0.09 0.27± 0.10 0.25± 0.09 1.60+0.24*
Cateehol: :::- :--: ----: 0.27±005 0.32: 0 --:6 01.
Phenylglucuronide 0.41 0.07 0.60 0.07 0.96 0.09* 0.67 0.12 Fi
(Muco.ic eddY1 0.03±0.02 0.06 ±0.0 .: 0,05±0.02 0.. in\
Phenol 0.16 0.05 0.09 0.04 0.08 0.02* 0.24±0.08
Others.;,,,:::,:' , ,::0.14±0.08 0.1 :0.. ..0: :; ..... 0 . .......' wer Total 2.67 2.62 2.79 7.51 ~~~--~~~-------- - ~~quir
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,rosomes isolated from rats treated with saline or
n oil (o), phenobarbital (*), or 3-methylcholan-
ene (v). Microsomes supplemented with UDP-
curonic acid were incubated with various
icentrations of hydroquinone. The reaction was lin-
*over 30 min. Data represent mean ± SD from three
eriments.
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lure 3. Glucuronidation of hydroquinone and phenol
V79 cells expressing rat UGT1.6. V79 wild type
A) and stably UGT1.6-transfected (,A) V79 cells
re incubated with 200 pM phenol (o,e) or hydro-
none (A,A). Glucuronides were analyzed by HPLC
described in "Materials and Methods." Data repre-
t mean ±SD from three experiments.
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"Rat hepatocytes were incubated with 0.1 mM benzene. bMean ± SD from four experiments. clncluding conjugates
of catechol. dCharacterized on the basis of retention. *Significantly different from controls at p<0.05.
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Figure 4. Western blotting of microsomal fractions of
hepatocytes isolated from untreated controls (C), and
from rats treated with isopropanol (Iso), 3-methyl-
cholanthrene (3-MC) or phenobarbital (PB). Each lane
contained 4.2 pg microsomal protein.
glucuronides were formed in untransfected
cells, UGT1.6-expressing cells showed a
considerable rate of glucuronidation of
both PH and HQ.
The most important phase I enzyme
involved in benzene metabolism is
CYP2E1 (18,19). Western blot analysis of
microsomes prepared from freshly isolated
hepatocytes showed that both 3-MC and
PB treatment decreased hepatic CYP2E1,
whereas the well-known inducing action of
short-chained aliphatic alcohols could be
confirmed in parallel experiments with
isopropanol (Figure 4).
Comparatively, the metabolism of
benzene in mouse hepatocytes was inves-
tigated. At least nine peaks detectable by
liquid scintillation counting could be sepa-
rated by HPLC (Figure 5). Most of the
metabolites were identical to those found
in rat hepatocytes, as revealed by mass
spectrometric analysis. However, two addi-
tional peaks were observed at a retention
time of7.0 min (peak 1) and around 10.0
min (peak 3). The compound eluting at
7.0 min could be isolated and identified by
FAB-MS as THB sulfate (not shown). The
compound eluting at around 10.0 min
coeluted with synthetic HQsulfate but did
not reveal a concisive FAB signal. However,
after treatment with diluted hydrochloric
acid overnight, HQwas detected in the El
mass spectrum (not shown).
Mouse hepatocytes metabolized 0.5
mM benzene at a 3-fold higher rate than
rat hepatocytes (Table 2). Furthermore,
considerable differences were found when
the quantitative patterns of metabolites
were compared. Rat hepatocytes did not
show formation ofTHB sulfate or HQsul-
fate, whereas in mouse hepatocytes ben-
zene-1,2-dihydrodiol was not found and
catechol formation was significantly lower.
The most pronounced differences were seen
with HQ (including HQ glucuronide),
which was found at a 10-fold higher
amount in mouse hepatocytes. The HQ
fraction probably comprises both HQ and
HQ glucuronide, which were not clearly
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Figure 5. HPLC radiochromatogram of 14C-benzene metabolites formed in isolated mouse hepatocytes.
Hepatocytes (20x106/20 ml) were incubated for 1 hr with 0.5 mM 14C-benzene (specific activity 37 MBq/mmol).
Fractions were collected at 0.3-min intervals and radioactivity was determined by liquid scintillation counting.
Numbers represent polar metabolites (A), 1,2,4-trihydroxybenzene sulfate (1), hydroquinone/hydroquinone glu-
curonide (2), hydroquinone sulfate (3), phenylsulfate/S-phenylglutathione (4), catechol (5), phenylglucuronide (6),
unidentified metabolite coeluting with trans-trans-muconic acid (7), phenol (8).
Table 2. Comparative analysis of metabolites formed in isolated rat and mouse hepatocytes.
nmol/hrx106cellsa % oftotal metabolites
Metabolite Wistarrat NMRI mouse Wistar rat NMRI mouse
Trihydroxybenzene sulfate - 0.72 ±0.41* - 5.3
Be no.dihyd:iol 0:- 09 :!0 .04 -:. ;:i.. 2.1
Hydroquinone/HQglucuronide 0.54 ± 0.04 6.14 ± 1.10* 12.4 45.0
Hydrvquina;I sulfate:1.65...0.2..-2 . .
Phenyl sulfate/phenylglutathione 1.76 ± 0.51 2.09 ± 0.62 40.3 15.3
.............0.65±0.40 031...0.12...49..2.3
Phenylglucuronide 0.97 0.61 1.45±0.23 22.2 10.6
.X. id IuM-foiccdb W0.2 0.2012090.9
Phenol 0.20 ±0.06 0.81 ±0.32* 4.6 5.9
~~~~~~~~~~~~~~~~~~~~~~ ;!. ... .... . :
Total 4.37 13.64 100.0 100.0
-, not detectable. aMean + SD from four experiments. bCoeluting with trans-trans-muconic acid. *Significantly
different from rat hepatocytes (p<0.05).
distinguishable by radiodetection. Further-
more, PH and metabolite 7, presumably
trans-trans-muconic acid, were found in
mouse hepatocytes at a 4-fold and 3-fold
higher level, respectively.
Discussion
This study's major aim was to explore the
pattern of benzene metabolites in hepato-
cytes, including phase II metabolism. The
combined radiodetection/direct mass spec-
trometry methods allowed the sensitive
detection, identification and quantification
of phase I metabolites and of intact
conjugates. The overall pattern of metabo-
lites was similar to that found in urine of
laboratory animals treated with benzene
(20,21), a finding that emphasizes the role
ofthe liver in benzene metabolism.
Treatment of rats with 3-MC, leading
to the induction of drug-metabolizing
enzymes that belong to the Ah gene bat-
tery, did not result in dramatic changes in
total benzene metabolism. However,
increased glucuronidation of PH at the
expense of PH sulfate formation suggest
involvement ofUGT1.6 (a member of the
Ah receptor gene battery that catalyzes the
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glucuronidation of planar phenols with
high affinity). Both 3-MC induction of
PH and HQ glucuronidation in liver
microsomes and the high glucuronidation
rates ofboth substrates in V79 cells express-
ing rat UGT1.6 suggest that UGT1.6
induction is the cause ofthe metabolic shift
toward PH glucuronidation. Apparent Km
values of0.14 mM for PH (15) and of0.1
mM for HQ characterize both compounds
as intermediate-affinity substrates of the
enzyme when compared to other planar
phenols (17,22). No glucuronide was
detectable in incubations of liver micro-
somes with THB, possibly as a result ofthe
high polarity ofTHB.
Another major effect ofinducing agents
was the pronounced enhancement of ben-
zene metabolism by isopropanol. Similar
observations were made by measuring ben-
zene metabolism in laboratory animals and
liver microsomes (23,24). In fact, the iso-
propanol-inducible isozyme CYP2E1 acts
as a high-affinity benzene monooxygenase
(18,19), and its induction thus led to an
increased formation ofa broad spectrum of
benzene metabolites, which are derived
directly or indirectly from benzene oxide.
A suprising result was the clear suppression
of CYP2E1 expression in hepatocytes
freshly isolated from 3-MC- (and PB-)
treated rats. Although the molecular basis
of this suppression is not known, it may
contribute to the protection toward the
myelotoxicity of benzene provided by 3-
MC-type inducers (25,26). At a substrate
concentration of0.1 mM, this suppression
was not reflected by a decreased rate of
total benzene metabolism in rat hepato-
cytes. However, incubations at lower
substrate concentrations showed a decrease
in total benzene metabolism after 3-MC
or PB treatment (27). The low yield of
metabolites, however, prevented the
quantification and identification ofindi-
vidual metabolites. Apparently, the con-
comitant induction oflow-affinity benzene
monooxygenases such as CYP1A2 or
CYP2B1 by these inducers at 0.1 mM ben-
zene counterbalances the decrease in
CYP2E1. It can be speculated that modifi-
cations of the hepatic CYP2E1 level may
have considerable consequences for the
toxicity ofbenzene at lower concentrations
in the range ofhuman exposure.
Since mice have been reported to be
more sensitive toward the carcinogenic
action of benzene (14), the patterns of
benzene metabolism in rat and mouse
hepatocytes were compared. A major
finding was that hepatocytes isolated from
NMRI mice metabolize benzene at a 3-fold
higher rate than hepatocytes from Wistar
rats (Table 2). This agrees with data pub-
lished by Henderson et al. (13) showing
that mice had considerably higher levels
of various benzene metabolites in liver,
lung, and blood after a 6-hr inhalation of
50 ppm benzene.
The comparison of metabolite patterns
formed in isolated hepatocytes from both
species also revealed qualitative differences.
A benzene metabolite detectable in super-
natants from mouse hepatocytes only was
identified as THB sulfate. Marked quanti-
tative differences were also found for HQ
and its conjugates. HQ (including HQglu-
curonide) and HQ sulfate taken together
accounted for more than 50% of total
metabolites in mouse hepatocyte incuba-
tions, whereas HQ was only a minor
metabolite in rat hepatocytes. In rats, evi-
dence for the excretion of HQ sulfate in
bile was obtained in a previous study (27).
Nevertheless, the rate offormation in rat
hepatocyte incubations was probably too
low to allow a clear separation and identifi-
cation ofthis compound. No evidence was
obtained for the formation ofHQdisulfate
in accordance with a report by Divincenzo
et al. (28).
Benzene-1,2-dihydrodiol, usually formed
in small amounts in rat hepatocytes, was
completely absent in mouse hepatocytes.
Similarly, rat hepatocytes produced more
catechol, which is in agreement with the
suggestion that benzene-1,2-dihydrodiol,
which was detected only in rat hepatocytes,
may be a precursor of catechol (3). The
fact that some catechol was also found in
mouse hepatocytes, however, suggests
either that it may be formed by an alterna-
tive pathway or that benzene-1,2-dihydro-
diol is converted more effectively to
catechol in mouse hepatocytes.
The most prominent differences found
by Henderson et al. (13) in an in vivo
study are basically in agreement with the
data presented here. The authors report
much higher levels of the putative myelo-
toxic metabolites HQ and HQ glu-
curonide in mouse tissues. However, the
reported considerable formation of trans-
trans-muconic acid was not confirmed in
the present study. This discrepancy may be
due to limitations in the comparison
between whole animals and cell cultures.
The pronounced differences in benzene
metabolism between rat and mouse hepa-
tocytes may have an important impact on
benzene toxicity. Since HQ is suspected to
mediate the myelotoxicity of benzene in
concert with other benzene metabolites
such as phenol or trans-trans-muconic acid,
a higher risk of myelotoxicity in mice
could be concluded from our experiments.
Furthermore, the higher rate offormation
of sulfate conjugates may represent an
additional pro-myelotoxic factor. Experi-
mental evidence in our laboratory suggests,
at least for HQ sulfate, a tendency for
hydrolysis and oxidation in an aqueous
environment. Recently, the instability of
the sulfate conjugate of 1,4-dihydroxy-
naphthalene in mice was demonstrated by
Tsuruda et al. (29). Similarly, THB sulfate
may provide a semistable transport form
for THB. THB was shown to be genotoxic
in Chinese hamster V79 cells (30); it may
also play a role in benzene myelotoxicity
(31). Thus, the role of HQ sulfate and
THB sulfate as putative pro-myelotoxic
metabolites and their activation in bone
marrow cells warrants further investigation.
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